B
buffalo
Guest
**It takes less than 30 seconds.
Tell Congress to Vote NO** on the unethical H.R. 810 (Stem Cell Research Enhancement Act of 2005) that funds killing human embryos with tax payer dollars. This bill already has 200 co-sponsors, just 18 short of the number needed to give the bill a majority vote in the House.
Instead, ask them to support the ethical H. R. 2520 (The Smith Stem Cell Therapeutic and Research Act of 2005) that funds promising adult stem cell research.
It is critical that we flood Congress today with calls and e-mails asking them to vote NO on H.R. 810 and YES on H.R. 2520. Please send an e-mail to your Congressman today.
In addition, call your Congressman’s office today and tell them you do not want your taxpayer dollars supporting the unethical killing of human embryos in the name of science! We have talking points and the contact information waiting for your use here. Please let us know once you have contacted your Congressman by e-mailing info@sba-list.org.
We all want to help cure life-threatening diseases like Parkinson’s and Alzheimer’s. Despite what the media portrays, there is ethical and promising research that is in need of funding.
Urge your Congressman to instead support the Smith Stem Cell Therapeutic and Research Act (H.R. 2520) introduced by Pro-life Congressman Chris Smith (NJ-04) which is also coming up for a vote TODAY.
This is a new federally funded stem cell research program for the scientifically sound collection and inventory of umbilical cord blood. This research has shown promising results and does not kill embryos!
Published studies have shown that cord blood stem cells have the capacity to change into other cells types, which give them the potential to treat many other debilitating conditions such as spinal cord injury, Parkinson’s, Diabetes and heart disease.
Thousands of patients have been successfully treated with cord blood cells for many diseases including Leukemia and Sickle Cell Anemia. More federal funds will make these treatments available to thousands more and will enable crucial research on this source of stem cells to continue.
Tell Congress to Vote NO** on the unethical H.R. 810 (Stem Cell Research Enhancement Act of 2005) that funds killing human embryos with tax payer dollars. This bill already has 200 co-sponsors, just 18 short of the number needed to give the bill a majority vote in the House.
Instead, ask them to support the ethical H. R. 2520 (The Smith Stem Cell Therapeutic and Research Act of 2005) that funds promising adult stem cell research.
It is critical that we flood Congress today with calls and e-mails asking them to vote NO on H.R. 810 and YES on H.R. 2520. Please send an e-mail to your Congressman today.
In addition, call your Congressman’s office today and tell them you do not want your taxpayer dollars supporting the unethical killing of human embryos in the name of science! We have talking points and the contact information waiting for your use here. Please let us know once you have contacted your Congressman by e-mailing info@sba-list.org.
We all want to help cure life-threatening diseases like Parkinson’s and Alzheimer’s. Despite what the media portrays, there is ethical and promising research that is in need of funding.
Urge your Congressman to instead support the Smith Stem Cell Therapeutic and Research Act (H.R. 2520) introduced by Pro-life Congressman Chris Smith (NJ-04) which is also coming up for a vote TODAY.
This is a new federally funded stem cell research program for the scientifically sound collection and inventory of umbilical cord blood. This research has shown promising results and does not kill embryos!
Published studies have shown that cord blood stem cells have the capacity to change into other cells types, which give them the potential to treat many other debilitating conditions such as spinal cord injury, Parkinson’s, Diabetes and heart disease.
Thousands of patients have been successfully treated with cord blood cells for many diseases including Leukemia and Sickle Cell Anemia. More federal funds will make these treatments available to thousands more and will enable crucial research on this source of stem cells to continue.